Immuneering CorporationIMRXNASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P43
Within normal range
Average
-14.91%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | -98.81% |
| Q3 2022 | -59.35% |
| Q2 2022 | -48.60% |
| Q1 2022 | -3.11% |
| Q4 2021 | -60.68% |
| Q3 2021 | -26.95% |
| Q2 2021 | -11.78% |
| Q1 2021 | 12.50% |
| Q4 2020 | -2.56% |
| Q3 2020 | 41.96% |
| Q2 2020 | -0.46% |
| Q1 2020 | 0.00% |